Back to the list
Congress: ECR25
Poster Number: C-27813
Type: Poster: EPOS Radiologist (scientific)
DOI: 10.26044/ecr2025/C-27813
Authorblock: S. El Graini, S. Cherkaoui, H. Retal, I. Dokal, Y. Omor, R. Latib, S. Amalik; Rabat/MA
Disclosures:
Soumya El Graini: Nothing to disclose
Sara Cherkaoui: Nothing to disclose
Hamza Retal: Nothing to disclose
Ibrahima Dokal: Nothing to disclose
Youssef Omor: Nothing to disclose
Rachida Latib: Nothing to disclose
Sanae Amalik: Nothing to disclose
Keywords: Oncology, MR, Diagnostic procedure, Metastases
References

  1. Peters S, Camidge DR, Shaw AT, et al. Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer. N Engl J Med. 2017, 377:829-38. doi: 10.1056/NEJMoa1704795.

  2. Fink KR, Fink JR. Imaging of brain metastases. Surg Neurol Int. 2013, 4(Suppl 4):S209-19. doi: 10.4103/2152-7806.111298.

  3. Nayak L, Abrey L, Iwamoto F. Intracranial dural metastases. Cancer. 2009, 115:1947-53. doi: 10.1002/cncr.24203.

  4. Singh S, Agris J, Leeds N, Ginsberg L. Intracranial leptomeningeal metastases: comparison of depiction at FLAIR and contrast-enhanced MR imaging. Radiology. 2000, 217:50-3. doi: 10.1148/radiology.217.1.r00oc3550.

  5. Hayashida Y, Hirai T, Morishita S, et al. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol. 2006, 27:1419-25. PMID: 16908550; PMCID: PMC7977525.

  6. Kerkhof M, Ganeff I, Wiggenraad RGJ, et al. Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy. J Neurooncol. 2018, 138:133-9. doi: 10.1007/s11060-018-2779-7.

  7. Jia C, Li Z, Guo D, et al. Brain metastases of non-small cell lung cancer: magnetic resonance spectroscopy for clinical outcome assessment in patients with stereotactic radiotherapy. Onco Targets Ther. 2020, 13:13087-96. doi: 10.2147/OTT.S286893. PMID: 33376357; PMCID: PMC7764647.
GALLERY